[Long-acting anabolic agent (clinibolin) as an adjuvant in tumor therapy].
D001798:Blood Proteins / Q000032:analysis; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy; D001984:Bronchial Neoplasms / Q000097:blood / Q000188:drug therapy; D005260:Female; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D008297:Male; D009277:Nandrolone / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy*; D010051:Ovarian Neoplasms / Q000097:blood / Q000188:drug therapy; D010592:Pharmaceutic Aids / Q000627:therapeutic use*; D013736:Testicular Neoplasms / Q000188:drug therapy; D014067:Tonsillar Neoplasms / Q000188:drug therapy; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy; D002583:Uterine Cervical Neoplasms / Q000097:blood / Q000188:drug therapy
D001798:Blood Proteins; D010592:Pharmaceutic Aids; D009277:Nandrolone
Langwirkendes Anabolikum (Clinibolin) als Adjuvans in der Tumortherapie.